JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:32-36, doi:10.1016/j.jacc.2006.02.060 (Published online 7 June 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinto, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinto, D. S.

Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents

Results From the TAXUS-IV Trial

Duane S. Pinto, MD, FACC*,*, Gregg W. Stone, MD, FACC{dagger}, Stephen G. Ellis, MD, FACC{ddagger}, David A. Cox, MD, FACC§, James Hermiller, MD, FACC||, Charles O’Shaughnessy, MD, FACC, J. Tift Mann, MD, FACC#, Roxana Mehran, MD, FACC{dagger}, Yingbo Na, MSc{dagger}, Mark Turco, MD, FACC**, Ronald Caputo, MD, FACC{dagger}{dagger}, Jeffrey J. Popma, MD, FACC{ddagger}{ddagger}, Donald E. Cutlip, MD, FACC*, Mary E. Russell, MD, FACC§§, David J. Cohen, MD, MSc* for the TAXUS-IV Investigators

* Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts
{dagger} Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York
{ddagger} Cleveland Clinic Foundation, Cleveland, Ohio
§ Mid Carolina Cardiology, Charlotte, North Carolina
|| St. Vincent’s Hospital, Indianapolis, Indiana
Elyria Memorial Hospital, Elyria, Ohio
# WakeMed, Raleigh, North Carolina
** Washington Adventist Hospital, Tacoma Park, Maryland
{dagger}{dagger} St. Joseph’s Hospital, Syracuse, New York
{ddagger}{ddagger} Brigham and Women’s Hospital, Boston, Massachusetts
§§ Boston Scientific Corporation, Natick, Massachusetts


Figure 1
View larger version (15K):

[in a new window]
 
Figure 1 Curves showing freedom from target vessel revascularization at 1 year among patients assigned to clinical follow-up alone (A) or to mandatory 9-month angiographic follow-up (B). Events are summarized as unadjusted Kaplan-Meier estimates and comparisons between the groups were made with a log-rank test.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.